The evolution of optimal functioning and maintenance of the immune system is thought to be driven by the costs arising from the allocation of resources to immune functions rather than to growth and reproduction and by the benefits arising from higher defence if an infection occurs. In young animals there is a high premium for fast growth and competitiveness and a parasite-mediated trade-off is thus predicted between the allocation of resources to growth versus immune function. In a field study on nestling great tits (Parus major), we manipulated simultaneously the level of immune defence by a dietary supplementation of the immunostimulant methionine and ectoparasite (Ceratophyllus gallinae) abundance in the nest and thereby assessed both the costs and benefits of investing in immune defence. Nestlings supplemented with methionine grew slower during the experimental boost of their immune system compared to controls. Thereafter, however, nestlings with a boosted immune system grew at faster rates under parasite pressure compared to unstimulated birds. It experimentally shows the costs and benefits of investment in immunity and suggests that the evolution of optimum host defence is governed by a parasite-mediated allocation trade-off between growth and immune function.
INTRODUCTION
Although the immune system of animals is a magnificent instrument for the defence against parasites, it is not perfect and considerable variation in immune system functioning is observed among individuals (Zuk & Stoehr 2002) . It has been suggested that both the investment in an effective immune defence machinery and/or its use are costly (e.g. Martin et al. 2003 ; reviewed in Sheldon & Verhulst 1996; Norris & Evans 2000) . Under natural conditions with limited access to energy and essential metabolites a higher investment in immune defence thus goes at the expense of investment in other traits such as growth (Soler et al. 2003; Brommer 2004) , predator avoidance (Rigby & Jokela 2000) or sexual signalling and reproduction (e.g. Gustafsson et al. 1994; Nordling et al. 1998; Siva-Jothy et al. 1998; Veiga et al. 1998; Moreno et al. 1999; Ilmonen et al. 2000; Bonneaud et al. 2003; Jacot et al. 2004; Ahtiainen et al. 2005) . Inherently the optimal solution for the resulting allocation trade-off (Sheldon & Verhulst 1996; Lochmiller & Deerenberg 2000; Norris & Evans 2000) is influenced by environmental factors, for example the risk of parasitism (Saino et al. 1998; Szép & Møller 1999; Merino et al. 2000) .
Showing the costs and benefits of investment in immunity as well as the optimal levels of resource allocation into immune functions is problematic in a non-experimental set-up due to the condition-dependence of both fitness and immunocompetence (Sheldon & Verhulst 1996; Norris & Evans 2000) . A direct, experimental manipulation of an individual's investment in immune defence is thus required. This might be either achieved by the use of lines artificially selected for high or low immunocompetence (e.g. Verhulst et al. 1999) or by supplementing individuals with immuno-enhancing drugs (Dietert et al. 1996) .
Nestling passerines are a good model system to experimentally investigate costs and benefits of differential investment in immunity by the latter method. They grow at fast rates and body mass at fledging correlates with both survival during the post-fledging period and recruitment to the breeding population (Tinbergen & Boerlijst 1990; Lindèn et al. 1992; Both et al. 1999) , implying high selective advantages of increased resource allocation to growth. However, early in life, young birds are also particularly vulnerable to parasites, due to both their limited mobility and their relatively naive immune system (Møller 1997) . Investment in immunological defence that reduces the impact of parasites might thus pay when a considerable risk of infection is anticipated (Wakelin 1996; Wikel et al. 1996) . Given the limited access to energy and nutrition under natural conditions, a trade-off between the investment into growth versus immune defence is thus predicted. This trade-off can be experimentally manipulated by supplementing nestling birds with methionine, a sulphur amino acid that enhances T-cell-functioning (Tsiagbe et al. 1987; Grimble & Grimble 1998) . Methionine is routinely used in poultry research to increase general performance, immunocompetence and resistance against infection (Grimble & Grimble 1998) , and has recently been used in two ecological field studies on magpies (Soler et al. 2003) and blue tits (Brommer 2004) to experimentally manipulate individual investment in immune defence. However, while Soler et al. (2003) and Brommer (2004) mainly concentrated on the experimental demonstration of the cost of immunity in terms of reduced growth or higher mortality, the aim of the present study was to assess both the costs and the benefits of an increased investment in immune defence in the presence and absence of parasites and thereby to explore the role of parasites in shaping the optimal solution of the investment trade-off between growth and immunity. We thus simultaneously manipulated the investment in immune function of great tit nestlings (Parus major) by an oral supplementation of an age-dependent dose of methionine and the load of their most common ectoparasite, the hen flea (Ceratophyllus gallinae) in a 2!2 design. We predict that an increased investment in immune defence is costly in terms of reduced growth rates, but that this investment pays if growing-up in the presence of parasites.
MATERIAL AND METHODS
(a) Study species The study was performed in 2004 in a population of great tits breeding in nest boxes in a mixed forest near Bern, Switzerland. The great tit is a small (16-20 g) hole-nesting passerine that produces one or two broods per year. It is one of the main hosts of the ectoparasitic hen flea ( Tripet & Richner 1997) . Hen fleas are nest-based parasites that suck blood from nestlings and adults and impair the fitness of their host by affecting growth, survival and future reproduction (Richner et al. 1993; Fitze et al. 2004 ).
(b) Experimental protocol One day after hatching of the nestlings we heat-treated all nests in a microwave oven to kill naturally present parasites (Richner et al. 1993) . Three days later, half the nests (nZ38 broods) were experimentally infested by 40 female and 20 male hen fleas whereas the other half (nZ37 broods) remained uninfested. The hen fleas used for the experimental infestation of the nests were obtained from old nest material collected at the beginning of the breeding season in the same forest.
Within each nest, nestlings were randomly assigned to the immune boosted (nZ233 nestlings) or the control (nZ254 nestlings) group. Immune boosted nestlings were supplemented with an age-dependent dose of methionine (DL-methionine, Sigma Chemicals, Germany) suspended in tap water (0.1 g ml K1 ). They received 100 ml of methionine suspension on day 4, 150 ml on day 5, 200 ml on day 6 and 7 and 250 ml on day 8 post-hatching, while the control nestlings received an equal quantity of tap water each day (Brommer 2004) . Methionine is a sulphur amino acid that is required in considerable amounts during immune defence. Methionine demands are covered by both endogenous production and dietary ingestion. Insufficient sulphur amino acid supply compromises glutathione synthesis, resulting in impaired T-cell production and functioning (Grimble & Grimble 1998) . Methionine is routinely provided in poultry farming to improve general performance and resistance against infection (Tsiagbe et al. 1987) .
(c) Nestling growth We measured the body mass gain of the nestlings (i) during the experimental boost of the immune system early in the nestlings' life (i.e. during the period of methionine supplementation) to assess the costs of an increased investment in immune defence and (ii) in the second half of the nestling period (i.e. after the nestlings had time to differentially invest in their immune defence in relation to their methionine treatment until shortly before fledging), to assess the benefits of their investment in immunity in relation to the manipulated parasite load in the nest. We therefore measured the body mass on day 4, before the start of the experimental boost of the immune system, on day 11, after the experimental manipulation of the nestlings' investment in immune defence had stopped and a third time on day 15 post-hatching, shortly before fledgling, using an electronic scale with a precision of 0.01 g. Growth early and late in the nestling period was calculated as the body mass gain from day 4 to day 11 and the body mass gain from day 11 to day 15, respectively. Nestling body mass was not significantly different between treatment groups at day 4 post-hatching, i.e. before the start of the methionine supplementation and parasite manipulation (nested ANOVA, brood: F 73,410 Z0.819, pZ0.851; parasite treatment: F 1,73 Z1.302, pZ0.258; methionine supplementation: F 1,410 Z1.346, pZ0.247; parasite treatment!methionine supplementation: F 1,410 Z0.448, pZ0.504). All nestlings were marked individually by clipping dorsal tufts on day 4 and were ringed with numbered aluminium rings on day 11.
(d) Immunocompetence
The T-cell-mediated immune response of the nestlings was assessed by a hypersensitivity assay using the lectin phytohaemagglutinin (PHA-P, Sigma Chemicals, Germany). The PHA assay provides a measure of the proliferative response of the circulating T lymphocytes to the injected mitogen (Goto et al. 1978; McCorkle et al. 1980; Cheng & Lamont 1988) . Nestlings were injected subcutaneously with 0.1 mg of PHA-P dissolved in 0.02 ml of sterile phosphate-buffered saline in the centre of the left wing-web (patagium) 13 days post-hatching. The thickness of the patagium at the injection site was measured with a micrometer (Mitotuyo, Type 2046FB-60) to the nearest 0.01 mm prior to and 24 h (G1 h) after injection. The thickness of the wing-web 5 s after applying the micrometer was used as a standardized measure of swelling (Tschirren et al. 2005) . The difference between the wing-web thickness before and 24 h after PHA injection was used as a measure of the cell-mediated immune response (Smits et al. 1999) . Repeatability of the measurement of wing-web thickness was high (rO0.9, Tschirren et al. 2003) . Measuring PHA response at the end of the nestling period and not e.g. after the methionine supplementation had stopped allowed demonstration that (i) methionine supplementation stimulates the T-cell mediated immune response, and probably also other components of the immune system that were not measured in this study, and that (ii) these immunostimulating effects lasted at least until the end of the nestling period, i.e. during the full second half of the nestling period when the beneficial effects of an increased investment in immune defence in relation to parasite abundance were assessed.
(e) Analyses Nested ANOVAs were used to analyse the effects of the parasite and the methionine treatment on immune response and growth early and late in the nestling period. Parasite treatment, methionine treatment and the interaction between the two factors were included as fixed factors into the models, and the nest, nested within parasite treatment, was included as a random effect. For the analysis of differences between immune boosted and control nestlings within a given parasite-infestation group we used individual contrasts. All tests were two-tailed with a significance level set at p%0.05.
Residuals of the models were tested for normality and homoscedasticity. Statistical analyses were performed using the JMP statistical software (Sall & Lehmann 1996 figure 1a,b) .
After the nestlings had time to build up a functional immune defence, i.e. in the second half of the nestling period after the methionine supplementation had stopped, immune boosted nestlings grew at faster rates than controls in parasite-infested nests (figure 2a, individual contrast: F 1,409 Z10.955, p!0.001) whereas in parasitefree nests the growth rate of immune-boosted and control nestlings did not differ significantly (figure 2b, individual contrast: F 1,409 Z0.2685, pZ0.555; nested ANOVA, brood: F 73,410 Z4.812, p!0.001; parasite treatment: F 1,73 Z0.072, pZ0.789; methionine supplementation: F 1,410 Z9.403, pZ0.002; parasite treatment!methionine supplementation: F 1,410 Z4.954, pZ0.027).
DISCUSSION
Methionine-supplemented nestlings showed a reduced body mass gain compared to control nestlings within the same nest during the experimental boost of the immune system. This result confirms previous studies on magpie and blue tit nestlings (Soler et al. 2003; Brommer 2004) , which demonstrated the costs of immunity in terms of reduced growth and higher mortality by a direct manipulation of an individual's investment in immune defence. Beside the negative effect of the methionine supplementation on growth rates, methionine supplemented nestlings also showed higher responses against an injection of PHA, a measure of the T-cell mediated immune response routinely used in ecological field studies. This result makes it unlikely that the reduced growth rates of supplemented birds in our study, as well as in Soler et al. (2003) or Brommer (2004) , are simply a result of detrimental effects of high methionine ingestion. The use of an experimental approach however highlights the trade-off between investment in immune defence and other life-history traits, i.e. the costs of an increased investment in immune defence in terms of reduced growth. These costs might reflect either the costs of building up powerful immune defence machinery, its use, or both. However, our experimental design does not allow for a direct separation and the discrimination between different costs will thus need further investigation. Furthermore, it is important to note that beside the T-cell mediated immune response assessed by the PHA assay, it is very likely that the supplementation of methionine also enhanced other components of the immune system, e.g. the humoral immune defence (e.g. Tsiagbe et al. 1987 ), which has not been assessed in our study.
To understand the evolution of optimum host defence one has to consider not only the costs but also the benefits of allocating resources into immune function (Sheldon & Verhulst 1996; Lochmiller & Deerenberg 2000; Norris & Evans 2000) . In a second step, our study thus assessed the benefits of an increased investment in immune defence by manipulating the abundance of the nestlings' most common ectoparasite, the hen flea, thereby complementing previous studies by Soler et al. (2003) and Brommer (2004) that experimentally manipulated investment in immune defence to assess the costs of immunity. We found that after the experimental manipulation of the nestlings' investment in immune defence, i.e. after the methionine supplementation had stopped, immune-boosted nestlings grew at significantly faster rates in parasite-infested nests compared to controls, whereas in parasite-free nests, immune-boosted and control nestlings did not grow at significantly different rates. This result cannot be explained by compensatory growth alone because compensatory growth would lead to higher growth rates of methionine supplemented nestlings irrespective of their parasite treatment, (i.e. to a significant main effect of the methionine treatment, but a non-significant interaction effect between parasite treatment and methionine treatment). The significant interaction effect between parasite treatment and methionine supplementation thus emphasizes the beneficial effects of an increased investment in immune defence when exposed to parasites. This beneficial effect might be due to specific or unspecific immune reactions-against hen fleas and/or pathogens that are potentially transmitted by the fleas during the blood meal ( Wakelin 1996; Wikel et al. 1996 )-which were stimulated by the methionine supplementation (see above).
In conclusion, our study experimentally demonstrates the costs of immunity in terms of reduced growth rates, as well as the benefits of a higher investment in immune defence in the presence of parasites. This suggests that the evolution of optimum host defence is governed by a parasite-mediated allocation trade-off between growth and immune function and illustrates that the evolution of trade-offs and their optima can only be understood when both costs and benefits are measured within an organism's natural environment.
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